glp 1 semaglutide dosage chart Weight Loss (Printable) empower semaglutide dosing chart Switching

Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD).

Meanwhile, patients are looking for solutions to any number of conditions with the hope that new treatments can provide more options or, perhaps, better outcomes

Learn about FDA-approved weight loss pills like Wegovy, Qsymia, Contrave, and Foundayo and how they compare to over-the-counter supplements.

Glucagon-like peptide-1 (GLP-1) is a peptide hormone secreted by the small intestine upon food intake

Nurse practitioner Tim Nicaise tried everything to lose weight without success